Deepview HHF Training and Validation Study

Inclusion criteria

• Willing and able to give informed consent, have a witnessed verbal consent, family discussion if intubated and retrospective consent for those that are intubated
• Life expectancy > 1 month
• Thermal burn mechanism (flame, scald, or contact)
• The Study Burn(s) occurred less than 72 hours prior to the time of first imaging
• Minimum burn wound size for adult or paediatric participants is 0.25% TBSA per region
• Have burn(s) on the head, hands and/or feet that meet the criteria for a Study Burn. If multiple regions meet the Study Burn criteria, per the discretion of the Investigator, all Study Burn regions should be included.

Exclusion criteria

• Sepsis at the time of enrolment
• Infection of the burn wound at the time of enrolment
• Immunosuppression / radiation / chemotherapy < 3 months prior to enrolment
• Concurrent use of investigational products with a known effect on the burn sites; and/or imaging
• Concurrent use of products such as chemical debriding agents, skin substitutes and others that the principal investigator deems will have an impact on the image quality and healing potential of a Study Burn
• Any condition that, in the opinion of the Investigator, may prevent compliance with the study requirements or compromise Participant safety
• Participants without a burn on the hands, feet, head or neck, or burns located on these regions only on the palmar or plantar surfaces
• Chemical or any other non-thermal burns

• Participants anticipated to or undergoing enzymatic debridemen9